(Q38393624)

English

Randomized study of traditional versus aggressive systolic blood pressure control (Cardio-Sis): rationale, design and characteristics of the study population

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

Randomized study of traditional versus aggressive systolic blood pressure control (Cardio-Sis): rationale, design and characteristics of the study population (English)

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

author name string

Cardio-Sis Study Group

1

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

publication date

29 November 2007

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

Journal of Human Hypertension

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

22

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

243-251

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

https://scigraph.springernature.com/pub.10.1038/sj.jhh.1002313

0 references

Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002313

21 January 2018

2007 Guidelines for the Management of Arterial Hypertension

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002313

21 January 2018

Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002313

21 January 2018

Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002313

21 January 2018

Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trial

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002313

21 January 2018

Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002313

21 January 2018

Electrocardiographic left ventricular hypertrophy and risk of coronary heart disease. The Framingham study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002313

21 January 2018

Reduction of cardiovascular risk by regression of electrocardiographic markers of left ventricular hypertrophy by the angiotensin-converting enzyme inhibitor ramipril

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002313

21 January 2018

Adverse prognostic significance of new diabetes in treated hypertensive subjects

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002313

21 January 2018

A historical perspective of elevated systolic vs diastolic blood pressure from an epidemiological and clinical trial viewpoint

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002313

21 January 2018

Guidelines for management of hypertension: report of the third working party of the British Hypertension Society

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002313

21 January 2018

Regression of electrocardiographic left ventricular hypertrophy during antihypertensive treatment and the prediction of major cardiovascular events

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002313

21 January 2018

Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002313

21 January 2018

Independent predictors of isolated clinic ('white-coat') hypertension.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002313

21 January 2018

Differential Control of Systolic and Diastolic Blood Pressure

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002313

21 January 2018

Identifiers

10.1038/SJ.JHH.1002313

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38393624&oldid=1757354030"